

(ShareCast News) - Credit Suisse has reiterated its 'outperform' rating on Shire Pharmaceuticals, along with a target of 5000p, ahead of its proposed ...


(ShareCast News) - Shire's shareholders have approved the company's $32bn merger with US-based Baxalta Inc. The Dublin-based pharmaceuticals group sai...